On a snapshot day in 2013, over 47,000 clients received pharmacotherapy treatment for their opioid dependence at 2,355 dosing points around Australia.
As in previous years, methadone was the most common pharmacotherapy drug, with around two-thirds (68%) of clients treated with this drug. There were 2,025 prescribers of opioid pharmacotherapy drugs, an increase of 15% from 2012.
ISSN 1447-6746; ISBN 978-1-74249-577-4; Cat. no. HSE 147; 86pp.; $13
Publication table of contents
- Preliminary material
- Title and verso pages
- Body section
- 1 Introduction
- What are opioid drugs?
- What problems can opioid dependence cause?
- What treatment is available?
- How is opioid pharmacotherapy provided in Australia?
- What information is included in the NOPSAD collection?
- What is new in the 2013 NOPSAD collection?
- What is the NOPSAD collection used for?
- 2 Clients
- How many people receive opioid pharmacotherapy treatment?
- What drugs do clients receive?
- Who receives pharmacotherapy treatment?
- Opioid drug of dependence and client status
- 3 Prescribers
- How are prescribers authorised?
- Where do prescribers work?
- How many clients do prescribers treat?
- Does drug treatment vary between sectors?
- 4 Dosing points
- What are the numbers and types of dosing points?
- What is the relationship between clients and dosing points?
- 5 Explanatory notes
- End matter
- Appendix A: Supporting tables
- Appendix B: NOPSAD 2013 Data quality statement
- Appendix C: Data requests and related data collections
- List of tables
- List of figures
- List of boxes
AIHW 2014. National Opioid Pharmacotherapy Statistics 2013. Drug treatment series 23. Cat. no. HSE 147. Canberra: AIHW.